STATE OF HEALTH CARE SUMMIT // AGENDA

STATE OF HEALTH CARE SUMMIT // AGENDA
February 13, 2015
Stay tuned for updates to the agenda’s speaker roster.
8:30 AM - 9:15 AM
Keynote Address: What Lies Ahead for Biotech in 2015?
The day will kick off with a keynote addressing trends that are shaping the biotech industry in 2015.
9:30 AM - 10:00 AM
Panel: Medical Device Innovation Drives Growth Higher
This panel will investigate new therapies such as transcatheter heart valves and drug-coated
balloons.
Speakers:
Jason McGorman, Analyst, Bloomberg Intelligence
10:00 AM - 10:30 AM
Panel: Innovation in Liver Diseases: HCV and NASH
The panel will discuss advances in the treatment of hepatitis C and fatty liver disease.
Speakers:
Keith Hoffman, V.P. Scientific Affairs, AdverseEvents
Dr. Hillel Tobias, NYU
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence
10:40 AM - 11:10 AM
Panel: Investor Outlook 2015
A discussion of what investors are most interested in for 2015.
Speakers:
Leon Chen, Ph.D., Venture Partner, OrbiMed
Andrew Hilgenbrink Director at Highland Capital Healthcare Partners
Les Funtleyder, Healthcare Portfolio Manager, E Squared Asset Management
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
11:10 AM - 11:40 AM
Panel: Cancer Innovation
The panel of key opinion leaders will discuss advances with immunotherapy and novel approaches
like CAR-T in blood cancers.
Speakers:
Michel Sadelain, MD, PhD, Memorial Sloan Kettering, cofounder Juno Therapeutics
Peter Emtage, Ph.D., Vice President, Synthetic Immunology, Intrexon
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence
11:40-11:55 Break
11:55 AM – 12:55 PM
Address: Bloomberg-BIO Joint Survey on 2015
Results of our survey of industry stakeholders and investors will be revealed.
Speakers:
Mark Schoenebaum, Senior Managing Director, Head of Evercore ISI's Health Care Research Team
Bernard Fallon, Senior Manager, Industry Research & Event Programming, Business Development
at BIO
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence
12:55-1:10 Break
1:10 PM - 1:45 PM
Panel: What's the Cost of Pricing Pressure?
Drug developers have been facing pushback on the price of drugs. The panel will explore ways in
which the healthcare system will deal with the rising price of novel therapies.
Speakers:
Dr. Robert Dubois, Chief Science Officer, National Pharmaceutical Council
Michael Kuehn, Simon Kucher Partners
Tanisha Carino, EVP, Life Sciences Avalere
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
1:45 PM - 2:15 PM
Panel: The Evolution of the U.S. Biosimilars Market
Experts will clarify complexities in the regulatory pathway for biosimilars and ramifications of ongoing
litigation.
Speakers:
Kevin M. Nelson, Partner, Duane Morris
Alex Waldron, VP of Global Commercial Operations, Epirus Biopharmaceuticals
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Aude Gerspacher, Senior Analyst, Bloomberg Intelligence
2:15 PM - 2:45 PM
Panel: Will ACA Reign Supreme in 2015?
A discussion of on-going challenges to the ACA and implications for the industry.
Speakers:
Michael Kolber, Attorney, Manatt, Phelps & Phillips, LLP
Greg Nersessian, Principal at Health Management Associates
Brian Rye, Healthcare Policy Analyst, Bloomberg Intelligence
Jason McGorman, Analyst, Bloomberg Intelligence
Aude Gerspacher, Senior Analyst, Bloomberg Intelligence
2:45 PM - 3:15 PM
Discussion: M&A in 2015
Find out what the hottest areas in M&A will likely be and whether 2015 will provide another year of
consolidation in the industry.
Speakers:
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence